Skip to main content
. 2022 Aug 18;9(8):277. doi: 10.3390/jcdd9080277

Figure 2.

Figure 2

Association of genetically predicted serum TIMP3 levels with risk of CAD and MI. TIMP3, tissue inhibitors of matrix metalloproteinase 3; CARDIoGRAMplusC4D, Coronary Artery Disease Genome−Wide Replication and Meta−Analysis plus the Coronary Artery Disease Genetics; OR, odds ratio; CI, confidence interval.